Clinical Trials Browser

Interventional × Castrate Resistance Prostate Cancer × Clear all

NCT06927635 2025-09-05

SECURE

Phase 2 Recruiting

Castrate Resistance Prostate Cancer

NCT04113005 2019-10-02

Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer

Phase EARLY_PHASE1 Unknown

Castrate Resistance Prostate Cancer